Concepedia

Richat Abbas

RA

Statistics

Publications

32

Citations

2.6K

H-Index

23

Active since

1997

Affiliations

Pfizer (United States)(Current)

Pfizer (France)

University of Colorado Denver

Wright-Patterson Air Force Base

Cleveland Clinic

Richat Abbas is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Top concepts

Publications per year

1997–2019

32

Publications

32

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Harold J. Burstein, Yan Sun, Luc Dirix et al. · Journal of Clinical Oncology · 2010 · 523 citations · Full text

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf et al. · Blood · 2011 · 457 citations

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

Kwok-K. Wong, Paula M. Fracasso, Ronald M. Bukowski et al. · Clinical Cancer Research · 2009 · 302 citations · Full text

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2–Dependent and Other Solid Tumors

Leena Gandhi, Rastislav Bahleda, Sara M. Tolaney et al. · Journal of Clinical Oncology · 2013 · 197 citations

A Human Physiologically Based Pharmacokinetic Model for Trichloroethylene and Its Metabolites, Trichloroacetic Acid and Free Trichloroethanol

Jeffrey W. Fisher, Deirdre A. Mahle, Richat Abbas · Toxicology and Applied Pharmacology · 1998 · 118 citations

, , +12

1–5 of 32